Conflicting rulings by federal judges leaves state of abortion pill in limbo

Dueling decisions from federal judges over the FDA's approval of mifepristone, one of the main medications used to provide abortions, mark the latest flash point in the fight over reproductive rights. The two decisions are the most significant abortion rulings since the U.S. Supreme Court overturned Roe v. Wade last summer. Mary Ziegler joined Geoff Bennett to discuss the legal path ahead.